The Motley Fool. DATE Wednesday, July 23, 2025 at 11 a.m. ET Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Founder, Chairman ...

The Motley Fool. DATE Wednesday, July 23, 2025, at 10 a.m. EDT CALL PARTICIPANTS Chairman and Chief Executive Officer — Richard AdkersonPresident and Chief Financial Officer — Kathleen QuirkSenior ...

A copy of the presentation ... website following the session. Tonix Pharmaceuticals Holding Corp.* Tonix is a fully-integrated biotech company focused on transforming therapies for pain management and ...

Doha, Qatar – Qatar Career Development Center (QCDC), founded by Qatar Foundation (QF), participated in the prestigious ...

Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (“Paladin” or the “Company”) advises that it has released its quarterly ...

BENEFIT, the Kingdom’s innovator and leading company in Fintech and electronic financial transactions service, took part in ...

(NASDAQ: HAS), a leading games, IP, and toy company, today reported financial results for the second quarter 2025. "Hasbro’s ...

IPO/MergerXlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 17.07.2025 / 07:00 CET/CESTThe filing demonstrates continued momentum ...

Renesas’ RA8P1 AI MCU combines Arm Cortex-M85 and M33 cores with the Ethos-U55 NPU, delivering AI performance up to 256 GOPs.

Roivant Sciences' 44% return highlights potential in its pipeline and partnerships. I maintain a cautious stance on RIOV stock due to competitive pressures. See more.

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX stock is a Buy.

Atlas Capital Group made a presentation of what town officials say was a "conceptual proposal" to Bloomfield's Planning and ...